MEDISING CIC

Company limited by guarantee

Company Registration Number:
11973048 (England and Wales)

Unaudited statutory accounts for the year ended 31 May 2023

Period of accounts

Start date: 1 June 2022

End date: 31 May 2023

MEDISING CIC

Contents of the Financial Statements

for the Period Ended 31 May 2023

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes
Community Interest Report

MEDISING CIC

Directors' report period ended 31 May 2023

The directors present their report with the financial statements of the company for the period ended 31 May 2023

Principal activities of the company

The principal activities of the company in the year under review were those of training and assisting communitymusicians working in the area of health and wellbeing.



Directors

The directors shown below have held office during the whole of the period from
1 June 2022 to 31 May 2023

N Wydenbach
A V Mallett
J E Chapman


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
20 February 2024

And signed on behalf of the board by:
Name: N Wydenbach
Status: Director

MEDISING CIC

Profit And Loss Account

for the Period Ended 31 May 2023

2023 2022


£

£
Turnover: 525 2,500
Cost of sales: 0 ( 2,500 )
Gross profit(or loss): 525 0
Distribution costs: 0 0
Administrative expenses: ( 531 ) ( 828 )
Other operating income: 0 0
Operating profit(or loss): (6) (828)
Interest receivable and similar income: 0 0
Interest payable and similar charges: 0 0
Profit(or loss) before tax: (6) (828)
Tax: 0 0
Profit(or loss) for the financial year: (6) (828)

MEDISING CIC

Balance sheet

As at 31 May 2023

Notes 2023 2022


£

£
Fixed assets
Intangible assets:   0 0
Tangible assets:   0 0
Investments:   0 0
Total fixed assets: 0 0
Current assets
Stocks:   0 0
Debtors:   0 0
Cash at bank and in hand: 3,872 4,073
Investments:   0 0
Total current assets: 3,872 4,073
Prepayments and accrued income: 0 0
Creditors: amounts falling due within one year: 3 ( 5,035 ) ( 5,230 )
Net current assets (liabilities): (1,163) (1,157)
Total assets less current liabilities: (1,163) ( 1,157)
Creditors: amounts falling due after more than one year:   0 0
Provision for liabilities: 0 0
Accruals and deferred income: 0 0
Total net assets (liabilities): (1,163) (1,157)
Members' funds
Profit and loss account: (1,163) ( 1,157)
Total members' funds: ( 1,163) (1,157)

The notes form part of these financial statements

MEDISING CIC

Balance sheet statements

For the year ending 31 May 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 20 February 2024
and signed on behalf of the board by:

Name: N Wydenbach
Status: Director

The notes form part of these financial statements

MEDISING CIC

Notes to the Financial Statements

for the Period Ended 31 May 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates,value added tax and other sales taxes.

    Other accounting policies

    TaxationTaxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except tothe extent that it relates to items recognised in other comprehensive income or directly in equity.Current or deferred taxation assets and liabilities are not discounted.Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted orsubstantively enacted by the balance sheet date.Deferred taxDeferred tax is recognised in respect of all timing differences that have originated but not reversed at the balancesheet date.Timing differences arise from the inclusion of income and expenses in tax assessments in periods different fromthose in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws thathave been enacted or substantively enacted by the year end and that are expected to apply to the reversal of thetiming difference.Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that theywill be recovered against the reversal of deferred tax liabilities or other future taxable profits.

MEDISING CIC

Notes to the Financial Statements

for the Period Ended 31 May 2023

  • 2. Employees

    2023 2022
    Average number of employees during the period 3 3

MEDISING CIC

Notes to the Financial Statements

for the Period Ended 31 May 2023

3. Creditors: amounts falling due within one year note

2023 2022
£ £
Bank loans and overdrafts 0 0
Amounts due under finance leases and hire purchase contracts 0 0
Trade creditors 0 0
Taxation and social security 0 0
Accruals and deferred income 4,725 4,920
Other creditors 310 310
Total 5,035 5,230

COMMUNITY INTEREST ANNUAL REPORT

MEDISING CIC

Company Number: 11973048 (England and Wales)

Year Ending: 31 May 2023

Company activities and impact

2022/23 was a strategic year to find funding to complete the singing app for people living with Parkinson's which resulted in a successful application to the Arts Council that will be actioned and completed in 2024. 2022/23 also saw the development of an online singing group that was successfully trialled in 2023.

Consultation with stakeholders

No consultation with stakeholders

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
20 February 2024

And signed on behalf of the board by:
Name: N Wydenbach
Status: Director